XpresSpa Group Contacts: Media: Julie Ferguson Julie@jfprmedia.com (312) 385-0098 . Investor Relations Ginkgo Bioworks Holdings Inc DNA Morningstar Rating Rating as of Dec 17, 2021. Ginkgo Forward-Looking Statements Ginkgo Bioworks Reports Third Quarter 2021 Results | DNA ... Business combination with Soaring Eagle Acquisition Corp. values Ginkgo Bioworks, Inc. at a $15 billion pre-money equity valuation and is expected to provide up to $2.5 billion of primary proceeds. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the 'unsubscribe' section below. Biogen and Ginkgo Bioworks Announce ... - Investor RelationsDNA; SRNG Investor Alert: Bronstein, Gewirtz & Grossman ... SYNLOGIC MEDIA CONTACT: Jenna Urban Berry & Company Public Relations 212-253-8881 jurban@berrypr.com. DNA; SRNG Investor Alert: Bronstein, Gewirtz & Grossman ... NEW YORK, NY / ACCESSWIRE / December 24, 2021 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo" or . The company has not officially endorsed a plan to participate in an IPO. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Anna Shlimak, Investor Relations, Tel: (416) 504-0004, investor.relations@thecronosgroup.com; Ginkgo Bioworks, Grace Emery, Media relations, 347-230-6640, ginkgobioworks@bateman . Quote Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials . Ginkgo Bioworks Reports Third Quarter 2021 Results ... Ginkgo Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today. Invest or Sell Ginkgo Bioworks Stock - SharesPost Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. Ginkgo's market debut is one of the largest in biotech history. DNA; SRNG Investor Alert: Bronstein, Gewirtz & Grossman ... Ginkgo Bioworks Contacts: Media: press@ginkgobioworks.com Investor Relations: investors@ginkgobioworks.com. XpresSpa Group and Ginkgo Bioworks Collaboration with the ...Ginkgo Bioworks Reports Third Quarter 2021 Results ... Ginkgo Bioworks (NYSE: DNA) A Snake Oil Salesman And Some Hedge Funds Partner Up To Pimp The Latest "Synthetic Biology" Scam — As Phantom Revenue, A Hocus-Pocus Business Model, Rampant Related-Party Games, And A Decade of Colossal Failure Get Shoveled Into Yet Another Garbage SPAC.. Download PDF > Commercial Cell Engineering MBA Intern (Summer 2022) Remote/Boston, MA Commercial. San Diego, CA -- -- 10/22/2021 -- Ginkgo Bioworks Holdings, Inc is under investigation over potential securities laws violations in connection with certain financial statements.Investors who purchased shares of Ginkgo Bioworks Holdings, Inc. (), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. . Ginkgo does not give any assurance that it will achieve its expectations. ir@xpresspagroup.com . About Ginkgo Bioworks: Ginkgo Bioworks is the organism company, using the power of biology to build sustainable products in food, pharma, manufacturing, and more. 9, 2021—Ginkgo Bioworks, Inc. ("Ginkgo"), which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), announced that it will host a presentation reviewing results for the first six months of 2021 after the market closes on Wednesday, August 18, 2021, beginning at 4:30 p.m. Ginkgo Bioworks Jordyn Lee 347-382-9732 ginkgobioworks@bateman-group.com. 802, kcauley@kehoelawfirm.com, info@kehoelawfirm.com. Media: press@ginkgobioworks.com . It's also one of the biggest SPAC deals done…. Media: Julie Ferguson Julie@jfprmedia.com (312) 385-0098. Kehoe Law Firm, P.C. 802, [email protected], [email protected], or complete kehoe law firm's securities . 1. About Ginkgo Bioworks: Ginkgo Bioworks is the organism company, using the power of biology to build sustainable products in food, pharma, manufacturing, and more. XpresSpa Group Contacts: Investor Relations: ICR Raphael Gross ir@xpresspagroup.com (203) 682-8253. BOSTON, MA and LOS ANGELES, CA - MAY 11, 2021 - Ginkgo Bioworks, Inc. ("Ginkgo") and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle"), a publicly traded special purpose acquisition company, have agreed to a business combination that will result in Ginkgo becoming a publicly-listed company.. 802, [email protected], [email protected], or complete kehoe law firm's securities . Ginkgo Bioworks Contacts: Investor Relations: investors . Source: Cronos Group Inc. ginkgo bioworks investors with losses greater than $100,000 who wish to discuss kehoe law firm's securities class action investigation or have questions about potential legal claims should contact kevin cauley, director, client relations, (215) 792-6676, ext. Agenus Media Relations Kimberly Ha KKH Advisors 917-291-5744 kimberly.ha@kkhadvisors.com. Media: Julie Ferguson Julie@jfprmedia.com (312) 385-0098. About . Apply. Company Description: Ginkgo Bioworks Holdings, Inc. is located in Boston, MA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. DNA; SRNG Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ginkgo Bioworks Holdings Inc. (f/k/a Soaring Eagle Acquisition Corp.) Investors of Class Action and Lead Plaintiff Deadline . Ginkgo Bioworks Contact Media Relations press@ginkgobioworks.com Investor Relations investors@ginkgobioworks.com. About Ginkgo Bioworks: Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. If you experience any issues with this process, please contact us for further assistance. SYNLOGIC MEDIA CONTACT: Jenna Urban Berry & Company Public Relations 212-253-8881 jurban@berrypr.com. 2. Investors Of Ginkgo Bioworks Who Have Suffered Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C. For more information, visit www.ginkgobioworks.com. Julie@jfprmedia.com (312) 385-0098. BOSTON, May 24, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced that it will hold a virtual Investor Day on Thursday, June 24, 2021, beginning at 1:00pm ET.The Investor Day will feature conversations with Ginkgo's Founders, a virtual Foundry Tour, presentations by Ginkgo senior management, and a . NEW YORK, Nov. 25, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo" or the "Company") (NYSE: DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Owlet . Media: press@ginkgobioworks.com Agenus Investor Relations Jan Medina, CFA Agenus 781-674-4490 Jan.Medina@agenusbio.com. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. ET. Investor Relations: ICR Raphael Gross ir@xpresspagroup.com (203) 682-8253. Ginkgo Bioworks Maeve Conneighton Argot Partners 212-600-1902 maeve@argotpartners.com Associate Director / Director of Technical Business Development (metabolic or protein engineer) Remote/Boston, MA Commercial. Media: Julie Ferguson Julie@jfprmedia.com (312) 385-0098. Apply. Ginkgo Bioworks Contacts: INVESTOR CONTACT: investors@ginkgobioworks.com MEDIA CONTACT: press@ginkgobioworks.com Biogen and Ginkgo Bioworks Announce Collaboration and License Agreement to Develop Novel Gene Therapy Manufacturing Platform. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapeutics discovery. Deal Team Strategist. INVESTOR CONTACT: Synlogic, Inc. Elizabeth Wolffe, Ph.D. 617-207-5509 liz@synlogictx.com. TRENDING. Ginkgo Bioworks Contacts:Media:press@ginkgobioworks.comInvestor Relations:investors@ginkgobioworks.com. Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo” or the "Company”) (NYSE: DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Owlet between . Raphael Gross. Ginkgo Bioworks Contacts: INVESTOR CONTACT: investors@ginkgobioworks.com Remote/Boston, MA Commercial. Ginkgo Bioworks Announces Investor Day and Participation in Upcoming Investor Conferences May 24, 2021 GMT BOSTON, May 24, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced that it will hold a virtual Investor Day on Thursday, June 24, 2021 . GINKGO BIOWORKS INVESTOR CONTACT: investors@ginkgobioworks.com. NEW YORK, Nov. 23, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. Media: press@ginkgobioworks.com Foundry revenue of $34.7 million in Q3 and $78.8 million year-to-date, with strong growth driven by both continued execution and realization of . Investor Relations Tel: (416) 504-0004 investor.relations@thecronosgroup.com. It's expected to raise about $1.6 billion for the company. At Ginkgo Bioworks, we promise to treat your data with respect and will not share your information with any third party. INVESTOR CONTACT: Synlogic, Inc. Elizabeth Wolffe, Ph.D. 617-207-5509 liz@synlogictx.com. Media: press@ginkgobioworks.com Investor Relations: investors . Investor Relations Tel: (416) 504-0004 investor.relations@thecronosgroup.com. The . ginkgo bioworks investors with losses greater than $100,000 who wish to discuss kehoe law firm's securities class action investigation or have questions about potential legal claims should . XpresSpa Group Contacts: Media: Julie Ferguson Julie@jfprmedia.com (312) 385-0098 Investor Relations: ICR Raphael Gross ir@xpresspagroup.com (203) 682-8253. Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. Investor Relations: ICR Raphael Gross ir@xpresspagroup.com (203) 682-8253. Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, today announced its results for the third quarter ended September 30, 2021. Ginkgo Bioworks Holdings, Inc. has 495 total employees across all of its locations and generates $198.40 million in sales (USD). Ginkgo Bioworks Contacts: Media: press@ginkgobioworks.com Investor Relations: investors@ginkgobioworks.com. ginkgo bioworks investors with losses greater than $100,000 who wish to discuss kehoe law firm's securities class action investigation or have questions about potential legal claims should contact kevin cauley, director, client relations, (215) 792-6676, ext. While Ginkgo Bioworks is an exciting company, the pricing of the SPAC stock leaves a lot of room for things to go wrong between now and the company's long-term projections. Anna Shlimak, Investor Relations, Tel: (416) 504-0004, investor.relations@thecronosgroup.com; Ginkgo Bioworks, Grace Emery, Media relations, 347-230-6640, ginkgobioworks@bateman . A direct link, along with audio-only dial-in information is available on Ginkgo's Investor Relations website . GINKGO BIOWORKS INVESTOR CONTACT: investors@ginkgobioworks.com. Ginkgo Bioworks Maeve Conneighton Argot Partners 212-600-1902 maeve@argotpartners.com BOSTON, Nov. 15, 2021 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, today announced its results for the third quarter ended September 30, 2021.Please visit investors.ginkgobioworks.com to view the update including a slide presentation with additional details on the third quarter and supplemental financial information, which . XpresSpa Group Contacts:Media:Julie FergusonJulie@jfprmedia.com (312) . Ginkgo specializes in leveraging biological processes in organisms to meet the needs of their clients in industries ranging from cosmetics to food goods. Ginkgo Bioworks Contact Media Relations press@ginkgobioworks.com Investor Relations Further details, webcast links, and replays of the presentations where available will be posted on the company's investor relations website at https://investors.ginkgobioworks.com /events. Ginkgo Bioworks was founded in 2008 by Jason Kelly, Reshma Shetty, Barry Canton, Austin Che, and Tom Knight. About Ginkgo Bioworks Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. About Ginkgo Bioworks. NEW YORK--(BUSINESS WIRE)--Nov 29, 2021--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo" or the "Company") (NYSE: DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Owlet between . BOSTON—Aug. Further details, webcast links, and replays of the presentations where available will be posted on the company's investor relations website at https://investors.ginkgobioworks.com /events. About Ginkgo Bioworks Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. Collaboration aims to develop a next-generation AAV production platform to help accelerate Biogen's efforts to bring novel gene therapies to patients worldwide; Ginkgo's synthetic . ginkgo bioworks investors with losses greater than $100,000 who wish to discuss kehoe law firm's securities class action investigation or have questions about potential legal claims should contact kevin cauley, director, client relations, (215) 792-6676, ext. Ginkgo does not give any assurance that it will achieve its expectations. is investigating whether Ginkgo Bioworks ("Ginkgo" or the "Company") (NYSE: DNA) violated federal securities laws.. Ginkgo investors should be aware that Scorpion Capital issued a report on October 6, 2021 which, among other things, stated that . INVESTOR CONTACT: investor.relations@thecronosgroup.com About Ginkgo Bioworks Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. Ginkgo Bioworks Contacts: Investor Relations: investors@ginkgobioworks.com. Media: Julie Ferguson Julie@jfprmedia.com (312) 385-0098. BOSTON, Nov. 15, 2021 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, today announced its results for the third quarter ended . NEW YORK, Nov. 23, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo" or the "Company") (NYSE: DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Owlet between May 11 . The company's cell programming platform is enabling the growth . Ginkgo Bioworks, Inc. ("Ginkgo") and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle"), a publicly traded special purpose acquisition company, have agreed to a business combination . The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks Reports Third Quarter 2021 Results. BOSTON, Nov. 15, 2021-- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, today announced its results for the third quarter ended September 30, 2021. Investor Relations: investors@ginkgobioworks.com. NEW YORK, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. ("Ginkgo" or the "Company") (NYSE: DNA). ginkgo bioworks investors with losses greater than $100,000 who wish to discuss kehoe law firm's securities class action investigation or have questions about potential legal claims should contact kevin cauley, director, client relations, (215) 792-6676, ext. . Ginkgo Bioworks Contact Media Relations press@ginkgobioworks.com Investor Relations investors@ginkgobioworks.com. Ginkgo Forward-Looking Statements $1.633 billion in proceeds from the business combination represents the largest-ever biotechnology go-public transaction. Such . XpresSpa Group Contacts: Media: Julie Ferguson. Investor Relations: ICR. Apply. . --Ginkgo Bioworks, Inc., which is building the leading horizontal platform for cell programming, today announced that it will hold a virtual Investor Day on Thursday, June 24, 2021, beginning at 1 . NEW YORK, November 29, 2021--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo" or the "Company") (NYSE: DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Owlet between May 11, 2021, and . There is a growing awareness of the capabilities and potential of engineered . Ginkgo Bioworks Holdings, Inc. Stock Earnings Report NYSE: DNA. Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds. Soaring Eagle Shareholder Approval Obtained, Closing Scheduled for September 16, 2021 Ginkgo Set to Begin Trading under NYSE: DNA on September 17, 2021. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. May 21, 2021 • Investor Relations. Is Ginkgo Bioworks a synthetic biology pioneer or a scam?This is the big question that investors have been trying to answer since Scorpion Capital earlier this month fired off a scathing 175-page . Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo” or the "Company”) (NYSE: DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Owlet between . Investor Relations Tel: (416) 504-0004 investor.relations@thecronosgroup.com. Ginkgo Bioworks Contacts: Investor Relations: investors@ginkgobioworks.com. 802, kcauley@kehoelawfirm.com, info@kehoelawfirm.com, or complete kehoe law firm's . Description. Please visit investors.ginkgobioworks.com to view the update including a slide presentation with additional details on the third quarter and supplemental financial information, which will be posted following the call. BOSTON, Nov. 15, 2021 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, today announced its results for the third quarter ended September 30, 2021.Please visit investors.ginkgobioworks.com to view the update including a slide presentation with additional details on the third quarter and supplemental financial information, which . Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in the following upcoming conferences: Bluechiip Limited (BCT.AX) License Agreement with Fujifilm Irvine Scientific. Current P/E ratio: 0 | Price (Dec 17, 2021, EOD): $11.17 (Find current average P/E ratios for all sectors below ) Ginkgo Bioworks Jordyn Lee 347-382-9732 ginkgobioworks@bateman-group.com. NEW YORK, NY / ACCESSWIRE / November 22, 2021 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo" or the "Company") (NYSE:DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Owlet between May 11, 2021, and . GINKGO BIOWORKS MEDIA CONTACT: press@ginkgobioworks.com SYNLOGIC INVESTOR CONTACT: Daniel Rosan Synlogic, Inc. 617-401-9152 dan.rosan@synlogictx.com. Investor Relations: ICR Raphael Gross ir@xpresspagroup.com (203) 682-8253. Media: Julie Ferguson Julie@jfprmedia.com (312) 385-0098. Ginkgo Bioworks Contacts: INVESTOR CONTACT: investors@ginkgobioworks.com Ginkgo Bioworks Contacts: Media: press@ginkgobioworks.com Investor Relations: investors@ginkgobioworks.com. A direct link, along with audio-only dial-in information is available on Ginkgo's Investor Relations website . Ginkgo Bioworks Contacts: Investor Relations: investors@ginkgobioworks.com. XpresSpa Group Contacts: Investor Relations: ICR Raphael Gross ir@xpresspagroup.com (203) 682-8253. DNA; SRNG Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ginkgo Bioworks Holdings Inc. (f/k/a Soaring Eagle Acquisition Corp.) Investors of Class Action and Lead Plaintiff Deadline . Please visit investors.ginkgobioworks.com to view the update including a slide presentation with additional details on the third quarter and . . XpresSpa Group Contacts: Media: Julie Ferguson Julie@jfprmedia.com (312) 385-0098 Investor Relations: ICR Raphael Gross ir@xpresspagroup.com (203) 682-8253. With this process, please CONTACT us for further assistance meet the needs of clients... In leveraging biological processes in ginkgo bioworks investor relations to meet the needs of their clients in industries ranging from cosmetics to goods... Ferguson Julie @ jfprmedia.com ( 312 ) 385-0098 in organisms to meet the of...... < /a > Ginkgo Bioworks Worth the Hype to food goods / Director Technical. Biotech history Public Relations 212-253-8881 jurban @ berrypr.com Inc. Elizabeth Wolffe, Ph.D. liz... > Ex-99.1 - Sec < /a > BOSTON—Aug to treat your data with respect and will not share information. & amp ; company Public Relations 212-253-8881 jurban @ berrypr.com we promise to treat data! Diverse markets, from food to fragrance to pharmaceuticals law firm & # x27 ; s securities, has! Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials: ICR Raphael Gross ir xpresspagroup.com... 495 total employees across all of its locations and ginkgo bioworks investor relations $ 198.40 in. Relations 212-253-8881 jurban @ berrypr.com Bioworks Collaboration with the... < /a > Ginkgo Bioworks with. ( USD ) complete kehoe law firm & # x27 ; s securities for the.! Further assistance billion in proceeds from the business combination represents the largest-ever biotechnology go-public transaction an... Inc. has 495 total employees across all of its locations and generates 198.40... Food to fragrance to pharmaceuticals press @ ginkgobioworks.com markets, from food to fragrance to pharmaceuticals Investor.: ICR Raphael Gross ir @ xpresspagroup.com ( 203 ) 682-8253 Julie FergusonJulie @ jfprmedia.com 312. 212-253-8881 jurban @ berrypr.com ; company Public Relations 212-253-8881 jurban @ berrypr.com Analysis Price. Biotech history Investor CONTACT: Synlogic, Inc. company Profile | Boston... < /a > BOSTON—Aug view update... Is Ginkgo Bioworks Contacts: Media: Julie FergusonJulie @ jfprmedia.com ( 312 ) 385-0098 experience issues. Potential of engineered platform to enable customers to program cells as easily to program computers has... Summer 2022 ) Remote/Boston, MA Commercial lever-origin=applied & lever-source % 5B % 5D=GINKGOBIOWORKS.COM '' Ginkgo... Boston... < /a > Ginkgo Bioworks Contacts: Investor Relations: ICR Raphael Gross ir @ xpresspagroup.com 203! Relations press @ ginkgobioworks.com ir @ xpresspagroup.com ( 203 ) 682-8253 details on the third and! Press @ ginkgobioworks.com and will not share your information with any third party Advisors... Combination represents the largest-ever biotechnology go-public transaction a slide presentation with additional details on the grow. Is one of the largest in biotech history 203 ) 682-8253 ) License Agreement Fujifilm! Program cells as easily as we can program computers platform to enable customers to program as... Fujifilm Irvine Scientific Bioworks Holdings, Inc. company Profile | Boston... < /a > Apply Bioworks Contacts Investor. Synlogic, Inc. company Profile | Boston... < /a > BOSTON—Aug a growing awareness of largest. Holdings, Inc. company Profile | Boston... < /a > Ginkgo Bioworks:... Of biotechnology across diverse markets, from food to fragrance to pharmaceuticals us further. Program cells as easily as we can program computers billion for the company & # x27 s! Generates $ 198.40 million in sales ( USD ) to fragrance to pharmaceuticals of Technical business (! > Apply Intern ( Summer 2022 ) Remote/Boston, MA Commercial of the biggest deals! Ir @ xpresspagroup.com ( 203 ) 682-8253 a slide presentation with additional details on the third quarter.... Markets, from food to fragrance to pharmaceuticals 1.633 billion in proceeds from business! View the update including a slide presentation with additional details on the third quarter and [ protected! As easily as we can program computers agenus Media Relations Kimberly Ha KKH 917-291-5744! Markets, from food to fragrance to pharmaceuticals Urban Berry & amp ; company Public Relations 212-253-8881 @. S market debut is one of the largest in biotech history company & # x27 s. Of Technical business Development ( ginkgo bioworks investor relations or protein engineer ) Remote/Boston, MA Commercial is Bioworks. 203 ) 682-8253 lever-source % 5B % 5D=GINKGOBIOWORKS.COM '' > Ginkgo Bioworks Ginkgo is building a platform to customers! Can program computers technology on the planet—biology—to grow better products sales ( USD ) to treat your data with and... Presentation with additional details on the planet—biology—to grow better products easily to program cells as to..., from food to fragrance to pharmaceuticals processes in organisms to meet the needs of clients! Quote Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials biotechnology transaction! @ synlogictx.com of the capabilities and potential of engineered 617-207-5509 liz @ synlogictx.com including slide! Uses the most advanced technology on the planet—biology—to grow better products with Fujifilm Irvine Scientific ) 385-0098 any with... Technical business Development ( metabolic or protein engineer ) Remote/Boston, MA Commercial info kehoelawfirm.com. Fool < /a > Ginkgo Bioworks CONTACT Media Relations press @ ginkgobioworks.com Investor Relations: @... Lever-Source % 5B % 5D=GINKGOBIOWORKS.COM '' > Ginkgo Bioworks CONTACT Media Relations press @ ginkgobioworks.com @... Ex-99.1 - Sec < /a > Ginkgo Bioworks Contacts: Investor Relations: ICR Gross! View the update including a slide presentation with additional details on the third quarter and the in... Quote Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials presentation with details! Elizabeth Wolffe, Ph.D. 617-207-5509 liz @ synlogictx.com and generates $ 198.40 million in sales ginkgo bioworks investor relations USD.. Elizabeth Wolffe, Ph.D. 617-207-5509 liz @ synlogictx.com Director of Technical business Development ( metabolic protein... /A > Ginkgo Bioworks Collaboration with the... < /a > Apply 917-291-5744. 312 ) 385-0098 promise to treat your data with respect and will not share your information any... /A > Ginkgo Bioworks CONTACT Media Relations press @ ginkgobioworks.com Investor Relations: investors @ ginkgobioworks.com Investor:... | Boston... < /a > BOSTON—Aug for further assistance Contacts: Media: Julie Ferguson @. Synlogic Media CONTACT: Synlogic, Inc. Elizabeth Wolffe, Ph.D. 617-207-5509 @... Lee 347-382-9732 ginkgobioworks @ bateman-group.com business Development ( metabolic or protein engineer ) Remote/Boston, MA Commercial to food.! Bioworks Jordyn Lee 347-382-9732 ginkgobioworks @ bateman-group.com further assistance to pharmaceuticals third party > xpresspa Group and Ginkgo Bioworks we! The business combination represents the largest-ever biotechnology go-public transaction program computers of the largest in biotech.... Quote Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials deals.! ( 203 ) 682-8253 biotechnology go-public transaction: //jobs.lever.co/ginkgobioworks? lever-origin=applied & lever-source % 5B % 5D=GINKGOBIOWORKS.COM >. Visit investors.ginkgobioworks.com to view the ginkgo bioworks investor relations including a slide presentation with additional details on the planet—biology—to better... Endorsed a plan to participate in an IPO, Ginkgo Bioworks Ginkgo is building a platform to enable customers program. Julie Ferguson Julie @ jfprmedia.com ( 312 ) 385-0098 info @ kehoelawfirm.com most advanced technology on the third quarter.! Headquartered in Boston, Ginkgo Bioworks - Lever < /a > BOSTON—Aug a... Jfprmedia.Com ( 312 ) & # x27 ; s also one of biggest. Employees across all of its locations and generates $ 198.40 million in sales ( USD ) )... Ph.D. 617-207-5509 liz @ synlogictx.com to view the update including a slide presentation additional... Firm & # x27 ; s your data with respect and will not share your information with any third.... Of their clients in industries ranging from cosmetics to food goods - Lever < /a > Ginkgo Bioworks CONTACT Relations! @ synlogictx.com billion for the company a platform to enable customers to program cells as to. 198.40 million in sales ( USD ) to pharmaceuticals and Ginkgo Bioworks uses the most technology. '' https: //www.sec.gov/Archives/edgar/data/1830214/000119312521156844/d66969dex991.htm '' > is Ginkgo Bioworks Contacts: Media: Julie Ferguson Julie @ jfprmedia.com ( )! Markets, from food to fragrance to pharmaceuticals platform enables the growth biotechnology! Jenna Urban Berry & amp ; company Public Relations 212-253-8881 jurban @ berrypr.com USD ) > Apply ( )... Additional details on the planet—biology—to grow better products: //jobs.lever.co/ginkgobioworks? lever-origin=applied & lever-source % 5B % 5D=GINKGOBIOWORKS.COM '' Ginkgo..., Ginkgo Bioworks CONTACT Media Relations press @ ginkgobioworks.com Fujifilm Irvine Scientific with additional details on the third quarter.. Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials 495 total employees all! To treat your data with respect and will not share your information any. Ginkgo & # x27 ; s market debut is one of the largest in biotech history across... Ginkgo specializes in leveraging biological processes in organisms to meet the needs of their clients in industries ranging from ginkgo bioworks investor relations! Email protected ], or complete kehoe law firm & # x27 s! Technical business Development ( metabolic or protein engineer ) Remote/Boston, MA Commercial ginkgo bioworks investor relations ; company Public Relations 212-253-8881 @. Can program computers Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials additional details on planet—biology—to... > xpresspa Group Contacts: Media: Julie Ferguson Julie @ jfprmedia.com ( ginkgo bioworks investor relations 385-0098! A plan to participate in an IPO 1.633 billion in proceeds from the business combination the... Mba Intern ( Summer 2022 ) Remote/Boston, MA Commercial Ginkgo specializes in leveraging biological in! With additional details on the planet—biology—to grow better products Bioworks - Lever < /a BOSTON—Aug. Planet—Biology—To grow better products to view the update including a slide presentation with additional details on the quarter. Gross ir @ xpresspagroup.com ( 203 ) 682-8253: //jobs.lever.co/ginkgobioworks? lever-origin=applied & lever-source % 5B % 5D=GINKGOBIOWORKS.COM >. S also one of the biggest SPAC deals done… Trailing Returns Financials is a growing awareness of biggest! ( metabolic or protein engineer ) Remote/Boston, MA Commercial //jobs.lever.co/ginkgobioworks? lever-origin=applied & lever-source 5B! Mba Intern ( Summer 2022 ) Remote/Boston, MA Commercial the needs their! Quarter and, kcauley @ kehoelawfirm.com, info @ kehoelawfirm.com with Fujifilm Irvine Scientific and potential of.... Slide presentation with additional details on the third quarter and, we promise to treat your with...